A puzzling case of portal hypertension in a patient with human immunodeficiency and hepatitis C virus co-infection;Hypertension portale chez un malade coinfecté par le virus de l'immunodéficience humaine et le virus de l'hépatite C

Gastroenterologie Clinique et Biologique

Volumn 31, Issue 10, 2007, Pages 878-880

  Mallet, Vincent ^a   Pol, Stanislas ^b  

^a Hôpital Cochin ^*  (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; ATAZANAVIR; BILIRUBIN; DIDANOSINE; GAMMA GLUTAMYLTRANSFERASE; LAMIVUDINE; RITONAVIR;

ADULT; ALBUMIN BLOOD LEVEL; ALCOHOLISM; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHRONIC LIVER DISEASE; CIGARETTE SMOKING; DEEP VEIN THROMBOSIS; FIBERSCOPE ENDOSCOPY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; HYPERPLASIA; LIVER BIOPSY; MALE; PORTAL HYPERTENSION; RISK FACTOR; SUPERINFECTION; VASCULAR DISEASE; VASCULAR LESION;

EID: 37149022612     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(07)73984-2     Document Type: Short Survey

References (24)

1. Lewden C, Salmon D, Morlat P, Bevilacqua S, Jougla E, Bonnet F, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol 2005;34:121-30.
2. Salmon-Ceron D, Lewden C, Morlat P, Bevilacqua S, Jougla E, Bonnet F, et al. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol 2005;42:799-805.
3. Nunez M. Hepatotoxicity of antiretrovirals: incidence, mechanisms and management. J Hepatol 2006;44:S132-9.
4. Maida I, Nunez M, Rios MJ, Martin-Carbonero L, Sotgiu G, Toro C, et al. Severe Liver Disease Associated With Prolonged Exposure to Antiretroviral Drugs. J Acquir Immune Defic Syndr 2006;42:177-82.
5. Schiano TD, Kotler DP, Ferran E, Fiel MI. Hepatoportal Sclerosis as a Cause of Noncirrhotic Portal Hypertension in Patients With HIV. Am J Gastroenterol 2007.
6. Sandrine PF, Sylvie A, Andre E, Abdoulaye D, Bernard L, Andre C. Nodular regenerative hyperplasia: a new serious antiretroviral drugs side effect? AIDS 2007;21:1498-9.
7. Mallet V, Blanchard P, Verkarre V, Vallet-Pichard A, Fontaine H, Lascoux-Combe C, et al. Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients. AIDS 2007;21:187-92.
8. Garvey LJ, Thomson EC, Lloyd J, Cooke GS, Goldin RD, Main J. Response to Mallet et al., "Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients". AIDS 2007;21:1494-5.
9. Arey B, Markov M, Ravi J, Prevette E, Batts K, Nadir A. Nodular regenerative hyperplasia of liver as a consequence of ART. AIDS 2007;21:1066-8.
10. Podevin P, Spiridon G, Terris B, Chauvelot-Moachon L, Guillevin L, Chaussade S, et al. Nodular regenerative hyperplasia of the liver after IL-2 therapy in an HIV-infected patient. AIDS 2006;20:313-5.
11. Naber AH, Van Haelst U, Yap SH. Nodular regenerative hyperplasia of the liver: an important cause of portal hypertension in non-cirrhotic patients. J Hepatol 1991;12:94-9.
12. Steiner PE. Nodular regenerative hyperplasia of the liver. Am J Pathol 1959;35:943-53.
13. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990;11:787-97.
14. Wanless IR, Godwin TA, Allen F, Feder A. Nodular regenerative hyperplasia of the liver in hematologic disorders: a possible response to obliterative portal venopathy. A morphometric study of nine cases with an hypothesis on the pathogenesis. Medicine (Baltimore) 1980;59:367-79.
15. Wanless IR, Solt LC, Kortan P, Deck JH, Gardiner GW, Prokipchuk EJ. Nodular regenerative hyperplasia of the liver associated with macroglobulinemia. A clue to the pathogenesis. Am J Med 1981;70:1203-9.
16. Reshamwala PA, Kleiner DE, Heller T. Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology 2006;44:7-14.
17. Mallet VO, Viard JP, Lasne D, Vallet-Pichard A, Pol S. Nodular regenerative hyperplasia in chronic human immunodeficiency virus infection is linked to protein S deficiency. Journal of Hepatology 2007;46:S274-S274.
18. Comp PC, Doray D, Patton D, Esmon CT. An abnormal plasma distribution of protein S occurs in functional protein S deficiency. Blood 1986;67:504-8.
19. Lafeuillade A, Alessi MC, Poizot-Martin I, Dhiver C, Quilichini R, Aubert L, et al. Protein S deficiency and HIV infection. N Engl J Med 1991;324:1220.
20. Sugerman RW, Church JA, Goldsmith JC, Ens GE. Acquired protein S deficiency in children infected with human immunodeficiency virus. Pediatr Infect Dis J 1996;15:106-11.
21. Levine AM, Vigen C, Gravink J, Mack W, Watts CH, Liebman HA. Progressive prothrombotic state in women with advancing HIV disease. J Acquir Immune Defic Syndr 2006;42:572-7.
22. Stahl CP, Wideman CS, Spira TJ, Haff EC, Hixon GJ, Evatt BL. Protein S deficiency in men with long-term human immunodeficiency virus infection. Blood 1993;81:1801-7.
23. Stahl D, Lacroix-Desmazes S, Misra N, Karmochkine M, Kaveri SV, Costagliola D, et al. Alterations of self-reactive antibody repertoires in HIV disease: an insight into the role of T cells in the selection of autoreactive B cells. Immunol Lett 2005;99:198-208.
24. Klein SK, Slim EJ, de Kruif MD, Keller TT, ten Cate H, van Gorp EC, et al. Is chronic HIV infection associated with venous thrombotic disease? A systematic review. Neth J Med 2005;63:129-36.